Back to Search
Start Over
1379P Margetuximab (M) with retifanlimab (R) in HER2+, PD-L1+ 1st-line unresectable/metastatic gastroesophageal adenocarcinoma (GEA): MAHOGANY cohort A.
- Source :
-
Annals of Oncology . 2021 Supplement 5, Vol. 32, pS1043-S1044. 2p. - Publication Year :
- 2021
- Subjects :
- *MAHOGANY
*ADENOCARCINOMA
*METASTASIS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152689573
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.08.1488